beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Term ID

CHEBI:65176

Synonyms

(Gal)1 (GlcNAc)1 (LFuc)1 (S)1
6-deoxy-alpha-L-galactopyranosyl-(1->3)-[3-O-sulfo-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
[3OSO3]Galbeta1-4[Fucalpha1-3]GlcNAc
alpha-L-fucopyranosyl-(1->3)-[3-O-sulfo-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-fucosyl-(1->3)-[3-O-sulfo-beta-D-galactosyl-(1->4)]-N-acetyl-D-glucosamine
beta-D-Gal3S-(1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[3-O-sulfo-beta-D-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
Lewis x-sulfated
O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[3-O-sulfo-beta-D-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-D-glucopyranose
sulfated Lewis X

Definition

An amino trisaccharide that consists of N-acetyl-D-glucosamine having an α-L-fucosyl residue attached at position 3 and a 3-sulfated β-D-galactosyl residue attached at position 4.

References

glygen:G26555CS
glytoucan:G26555CS
kegg.glycan:G01078
patent:JP2003235550
pubmed:10920004
pubmed:11679593
pubmed:12386453
pubmed:18565751
pubmed:19443021
pubmed:25568069
pubmed:31537530
pubmed:9405387
pubmed:9784103
reaxys:19308701

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype where environments contain beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype modified by environments containing beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype affecting beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Human Disease Model